$256 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 63 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Sell | Biogen Inc | $12,487,000 | -39.7% | 45,608 | -29.8% | 4.87% | -33.3% |
| REGN | Sell | Regeneron Pharmaceuticals | $12,407,000 | -19.2% | 36,030 | -11.8% | 4.84% | -10.6% |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $11,119,000 | -1.6% | 68,222 | -9.5% | 4.34% | +8.9% |
| EXEL | Sell | Exelixis Inc | $8,598,000 | -31.1% | 388,334 | -5.4% | 3.35% | -23.7% |
| BMRN | Sell | Biomarin Pharmaceutical Inc | $5,291,000 | -13.2% | 65,284 | -4.5% | 2.06% | -4.0% |
| SGEN | Sell | Seattle Genetics Inc | $2,223,000 | -27.8% | 42,500 | -26.1% | 0.87% | -20.1% |
| PRTK | Sell | Paratek Pharmaceuticals Inc | $1,346,000 | -70.3% | 103,500 | -59.2% | 0.52% | -67.2% |
| TSRO | Sell | Tesaro Inc | $1,217,000 | -81.0% | 21,300 | -72.4% | 0.48% | -79.0% |
| SGMO | Sell | Sangamo Therapeutics Inc | $1,004,000 | -66.9% | 53,000 | -71.4% | 0.39% | -63.4% |
| ACAD | Sell | Acadia Pharmaceuticals Inc | $961,000 | -90.4% | 42,773 | -87.2% | 0.38% | -89.4% |
| ANAB | Sell | Anaptysbio Inc | $885,000 | -48.3% | 8,500 | -50.0% | 0.34% | -42.8% |
| FOMX | Sell | Foamix Pharmaceuticals Ltd | $324,000 | -85.9% | 63,202 | -83.5% | 0.13% | -84.5% |
| XNCR | Exit | XENCOR INC | $0 | – | -18,000 | -100.0% | -0.14% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -15,000 | -100.0% | -0.20% | – |
| OMER | Exit | OMEROS CORP | $0 | – | -34,000 | -100.0% | -0.23% | – |
| Exit | MERUS NV | $0 | – | -75,060 | -100.0% | -0.50% | – | |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -204,538 | -100.0% | -0.78% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.80% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.81% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -115,500 | -100.0% | -0.89% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -108,000 | -100.0% | -1.06% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -36,104 | -100.0% | -2.21% | – |
| ENTL | Exit | ENTELLUS MED INC | $0 | – | -341,468 | -100.0% | -2.94% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -211,000 | -100.0% | -4.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.